Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)-Reference-Cited by-同舟云学术

Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)

Published:2023-10 Issue:2 Volume:117 Page:387-399
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zhou Rui,Qiu Bo,Xiong Mai,Liu YiMei,Peng KangQiang,Luo YiFeng,Wang DaQuan,Liu FangJie,Chen NaiBin,Guo JinYu,Zhang Jun,Huang XiaoYan,Rong YuMing,Liu Hui^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference45 articles.

1. Sequential versus concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

2. Concurrent chemotherapy and radiation therapy for inoperable locally advanced non-small-cell lung cancer;Rosenzweig;J Clin Oncol,2017

3. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003;Pfister;J Clin Oncol,2004

4. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

5. Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeated dynamic [18F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067);European Journal of Nuclear Medicine and Molecular Imaging;2024-07-02

2. Correlation of K^transderived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy;Journal for ImmunoTherapy of Cancer;2024-06

3. Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study;Clinical Cancer Research;2024-04-23

4. Radiation-induced dermatitis: a review of current understanding;Український радіологічний та онкологічний журнал;2024-03-22

5. Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2023-11